
    
      Methylnaltrexone will be given to pediatric patients post-operative from spinal fusion
      surgery on post-operative day number 3 and then again on postoperative day number 4, if no
      laxation achieved. Various outcome measures, safety and efficacy of the drug will be observed
      and recorded.
    
  